Electromagnetic Shock Wave Therapy Articles & Analysis
5 news found
WASHINGTON, Dec. 9, 2021 – BrainQ today announced that the first patient has been enrolled at MedStar National Rehabilitation Hospital in its pivotal, randomized, double-blind, multicenter trial, EMAGINE (the BQ5 Study). The trial is evaluating its frequency-tuned electromagnetic field treatment in facilitating recovery in individuals with moderately-severe ischemic stroke. The EMAGINE ...
Funding round led by Hanaco Ventures, joined by Dexcel Pharma and Peregrine Ventures, and existing investors. BrainQ’s investigational neurorecovery technology has been granted FDA Breakthrough Device Designation, and is set to be trialed in a multicenter pivotal study for stroke patients in select hospitals across the US. Jerusalem, Israel – August 16, 2021 – Israeli ...
JERUSALEM, March 11, 2021 -- BrainQ, the Israeli start-up with an AI-powered therapeutic platform, today revealed the encouraging results of their Randomized Controlled Trial (RCT) which supported a recently granted request for FDA Breakthrough Device Designation. The pilot trial data will be presented as part of the International Stroke Conference between March 17-19. In a single site, the ...
JERUSALEM, Feb. 11, 2021-- BrainQ, the Israeli start-up with a therapeutic solution to reduce disability following stroke, announced today that the United States Food and Drug Administration (FDA) has designated its AI-powered technology as a Breakthrough Device. The designation, which was based on BrainQ's latest randomized controlled clinical trial results for ischemic stroke patients, ...
U.S. Stem Cell Inc, a leader in regenerative medicine products and services, today announced its three partially owned Florida-based clinics have expanded their menu of services to help meet the growing market demand and patient needs for regenerative therapies. In addition to continuing to offer targeted stem cell therapies of all kinds — bone marrow, adipose, and tissue bank products ...